发明名称 |
Treating critically ill patients with intravenous ibuprofen |
摘要 |
Methods of treating at least one condition chosen from pain, inflammation, and fever in a critically ill patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen using a first dosage regimen, wherein the first dosage regimen produces a first pharmacokinetic profile in critically ill patients that is about equivalent to a second pharmacokinetic profile produced by administration of the intravenous pharmaceutical composition using a second dosage regimen of ibuprofen to non-critically ill patients, wherein the at least one condition of the critically ill patient is thereby treated. |
申请公布号 |
US8871810(B2) |
申请公布日期 |
2014.10.28 |
申请号 |
US200912646499 |
申请日期 |
2009.12.23 |
申请人 |
Cumberland Pharmaceuticals Inc. |
发明人 |
Pavliv Leo;Rock Amy Dix |
分类号 |
A01N37/10;A61K31/19;A61K31/197;A61K31/192 |
主分类号 |
A01N37/10 |
代理机构 |
Davidson, Davidson & Kappel, LLC |
代理人 |
Davidson, Davidson & Kappel, LLC |
主权项 |
1. A method of treating pain in critically ill patients in need thereof, comprising administering to critically ill patients an intravenous ibuprofen pharmaceutical composition in a dose of about 800 mg and providing a mean Cmax of about 60 μg/ml to treat pain in said patients, wherein the critically ill patients are not suffering from inflammation and are receiving at least one treatment selected from vasopressor support and mechanical ventilation. |
地址 |
Nashville TN US |